The Enterprise Value as of December 2025 (TTM) for Anxo Pharmaceutical Co., Ltd. (6677.TWO) is 1.61B

According to Anxo Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.61B. This represents a change of -28.52% compared to the average of 2.25B of the last 4 quarters.

Anxo Pharmaceutical Co., Ltd. (6677.TWO) Historical Enterprise Value (quarterly & annually)

How has 6677.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Anxo Pharmaceutical Co., Ltd. over the last ten years is 2.13B. The current 1.61B Enterprise Value has changed 7.46% with respect to the historical average. Over the past ten years (40 quarters), 6677.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 4.27B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Anxo Pharmaceutical Co., Ltd. (6677.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anxo Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anxo Pharmaceutical Co., Ltd. (6677.TWO) Average Enterprise Value

How has 6677.TWO Enterprise Value performed in the past?

The current Enterprise Value of Anxo Pharmaceutical Co., Ltd. (6677.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anxo Pharmaceutical Co., Ltd. (6677.TWO) Enterprise Value vs. Peers

How is 6677.TWO’s Enterprise Value compared to its peers?

Anxo Pharmaceutical Co., Ltd.’s Enterprise Value is less than Excelsior Biopharma Inc. (1.62B), less than Tien Liang BioTech Co., Ltd. (1.76B), greater than Great Novel Therapeutics Biotech & Medicals (1.29B), greater than Kim Forest Enterprise Co., Ltd. (1.42B), greater than DV Biomed Co., Ltd. (1.08B), greater than Prince Pharmaceutical Co., Ltd. (1.48B), less than Cowealth Medical Holding Co., Ltd. (1.76B), greater than GeneReach Biotechnology Corp. (1.26B), greater than Unicon Optical Co., Ltd. (1.27B), greater than Holy Stone Healthcare Co., Ltd. (1.10B),

Build a custom stock screener for Anxo Pharmaceutical Co., Ltd. (6677.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anxo Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anxo Pharmaceutical Co., Ltd. (6677.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anxo Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.